선택적 cyclooxygenase-2 억제제에 의한 간암세포의 성장억제에서 survivin 유전자 발현의 하향조절

키워드

참고문헌 (38)

1. Kerr JF, "Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics", Br J Cancer, 26, pp.239~257 (1972)
2. Rudin CM, "Apoptosis and disease: regulation and clinical relevance of programmed cell death", Annu Rev Med, 48, pp.267~281 (1997)
3. Dragovich T, "Signal transduction pathway that regulate cell survival and cell death", Oncogene, 17, pp.3207~3213 (1998)
4. Ambrosini G, "A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma", Nat Med, 3, pp.917~921 (1997)
5. Kawamura K, "Survivin acts as an antiapoptotic factor during the development of mouse preimplantation embryos", Dev Biol, 256, pp.331~341 (2003)
6. Schimmer AD, "Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice", Cancer Res, 64, pp.7183~7190 (2004)
7. Notarbartolo M, "Expression of IAPs and alternative splice variants in hepatocellular carcinoma tissues and cells", Ann N Y Acad Sci, 1028, pp.289~293 (2004)
8. Smith WL, "Prostaglandin endoperoxide H synthases (cyclooxygenase)-1 and 2", J Biol Chem, 271, pp.33157~33160 (1996)
9. Hla T, "Cyclooxygenase-1 and 2 isoenzymes", Int J Biochem Cell Biol, 31, pp.551~557 (1999)
10. Smith WL, "Why there are two cyclooxygenase isozymes", J Clin Invest, 107, pp.1491~1495 (2001)
11. Morita I, "Distinct functions of COX-1 and COX-2", Prostaglandins Other Lipid Mediat, 68,69, pp.165~175 (2002)
12. Singer II, "Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease", Gastroenterology, 115, pp.297~306 (1998)
13. Li HX, "Correlation between expression of cyclooxygenase-2 and angiogenesis in human gastric adenocarcinoma", World J Gastroenterol, 9, pp.674~677 (2003)
14. Gallo O, "Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis", Neoplasia, 3, pp.53~61 (2001)
15. Fujiwaki R, "Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase", Hum Pathol, 33, pp.213~219 (2002)
16. Gallo O, "Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma", Hum Pathol, 33, pp.708~714 (2002)
17. Cianchi F, "Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer", Gastroenterology, 121, pp.1339~1347 (2001)
18. Ristimaki A, "Expression of cyclooxygenase-2 in human gastric carcinoma", Cancer Res, 57, pp.1276~1280 (1997)
19. Eberhart CE, "Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas", Gastroenterology, 107, pp.1183~1188 (1994)
20. Zimmermann KC, "Cyclooxygenase-2 expression in human esophageal carcinoma", Cancer Res, 59, pp.198~204 (1999)
21. Tucker ON, "Cyclooxygenase-2 expression in up- regulated in human pancreatic cancer", Cancer Res, 59, pp.987~990 (1999)
22. Hida T, "Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas", Cancer Res, 58, pp.3761~3764 (1998)
23. Qiu DK, "Significance of cyclooxygenase-2 expression in human primary hepatocellular carcinoma", World J Gastroenterol, 8, pp.815~817 (2002)
24. Sawaoka H, "Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice", Am J Physiol, 274, pp.G1061~G1067 (1998)
25. Blumenthal RD, "Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts", Clin Cancer Res, 7, pp.3178~3185 (2001)
26. Williams CS, "Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models", Cancer Res, 60, pp.6045~6051 (2000)
27. Yamanaka Y, "COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis", Int J Mol Med, 18, pp.41~47 (2006)
28. Cheng AS, "Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells", Int J Oncol, 23, pp.113~119 (2003)
29. Kern MA, "Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells", Hepatology, 36, pp.885~894 (2002)
30. Li M, "Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway", Clin Cancer Res, 7, pp.1010~1016 (2001)
31. Sun Y, "Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells", Cancer Res, 62, pp.6323~6328 (2002)
32. Park MK, "NS398 inhibits the growth of Hep3B human hepatocellular carcinoma cells via caspase-independent apoptosis", Mol Cells, 17, pp.45~50 (2004)
33. Kern MA, "Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma", Cancer Res, 66, pp.7059~7066 (2006)
34. Li F, "Control of apoptosis and mitotic spindle checkpoint by survivin", Nature, 396, pp.580~584 (1998)
35. Kobayashi K, "Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation", Proc Natl Acad Sci U S A, 96, pp.1457~1462 (1999)
36. Pyrko P, "Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo", Mol Cancer, 5, pp.19~ (2006)
37. Sakoguchi-Okada N, "Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells", Biochem Pharmacol, 73, pp.1318~1329 (2007)
38. Davies NM, "Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor", Clin Pharmacokinet, 38, pp.225~242 (2000)

관련 논문AI추천